Recombinant human parvovirus B19 vectors

Pathologie Biologie

Volumn 50, Issue 5, 2002, Pages 295-306

  Weigel Kelley, Kirsten A ^a,b   Srivastava, Arun ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular receptor; Co receptor; Erythroid cells; Gene delivery; Gene expression, tissue tropism

Indexed keywords

VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL LINEAGE; CELL SURFACE; DNA VECTOR; ERYTHROID CELL; GENE EXPRESSION; HEMATOPOIETIC CELL; PARVOVIRUS; TARGET CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS RECOMBINANT; VIRUS STRAIN;

EID: 0036082022     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00310-3     Document Type: Article

References (71)

1. Use of adeno-associated virus as a general transduction vector for mammalian cells
2. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
3. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
4. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration
5. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
6. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells
7. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
8. Site-specific integration by adeno-associated virus
9. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
10. Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus
11. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
12. Adeno-associated viruses: An update
13. Biology of adeno-associated virus
14. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukemia cells are non-permissive for AAV infection
15. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
16. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
17. Experimental parvoviral infection in humans
18. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
19. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis
20. Embryonic malformations in a case of intrauterine parvovirus B19 infection
21. Fetal brain infection with human parvovirus B19
22. Human parvovirus B19 capsid antigen in granulocytes in parvovirus-B19-induced pancytopenia after bone marrow transplantation
23. Chronic bone marrow failure due to persistent B19 parvovirus infection
24. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection
25. Detection of parvovirus B19 DNA in fetal tissues by in situ hybridisation and polymerase chain reaction
26. Case report: Detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum
27. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro
28. Replication of the B19 parvovirus in human bone marrow cell cultures
29. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro
30. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow
31. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation
32. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver
33. Parvovirus B19 replication in human umbilical cord blood cells
34. Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood
35. Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02
36. First continuous propagation of B19 parvovirus in a cell line
37. Different patterns of restriction to B19 parvovirus replication in human blast cell lines
38. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells
39. Novel transcription map for the B19 (human) pathogenic parvovirus
40. Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19
41. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus
42. The 3′ untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells
43. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
44. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
45. Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes
46. Recombinant human parvovirus B19 vectors: Erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells
47. Construction of a recombinant human parvovirus B19: Adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus
48. + hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
49. Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
50. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells
51. Encapsidation of adenoassociated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells
52. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
53. Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells
54. Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors
55. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo
56. Adenoassociated virus 2-mediated transduction and erythroid cell-specific expression of a human beta-globin gene
57. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein
58. AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
59. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
60. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
61. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F
62. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
63. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
64. Identification of a major co-receptor for primary isolates of HIV-1
65. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
66. HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
67. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type I (HIV-1) entry: Evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3)
68. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein
69. Role of glycosphingolipids in HIV-1 entry: Requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion
70. + cells
71. Quantitative DNA slot blot analysis: Inhibition of DNA binding to membranes by magnesium ions